Stay updated on Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page shows a new revision number (v3.5.4) replacing v3.5.3, indicating a small site update. This change affects metadata rather than any study details.
    Difference
    0.1%
    Check dated 2026-05-15T05:38:43.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s footer revision/version has been updated from v3.5.2 to v3.5.3 for the ClinicalTrials.gov site software.
    Difference
    0.1%
    Check dated 2026-04-23T21:54:11.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Updated the site's release label from Revision: v3.5.0 to Revision: v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T12:26:59.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added: Revision v3.5.0; Removed: Revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T21:25:09.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T20:11:46.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. The government funding lapse notice and the older Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:35:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.